{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:44:09Z","timestamp":1774352649254,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.hroo.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T11:39:21Z","timestamp":1690457961000},"page":"528-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective"],"prefix":"10.1016","volume":"4","author":[{"given":"Oussama","family":"Wazni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Kuniss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Battista","family":"Chierchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Mealing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waruiru","family":"Mburu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Sale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle","family":"Kaplon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Ismyrloglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Bromilow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2023.07.007_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.hroo.2023.07.007_bib2","doi-asserted-by":"crossref","first-page":"k1717","DOI":"10.1136\/bmj.k1717","article-title":"Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies","volume":"361","author":"Adderley","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.hroo.2023.07.007_bib3","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.3390\/ijerph16173042","article-title":"Health-related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review","volume":"16","author":"Son","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.hroo.2023.07.007_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2023.07.007_bib5","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2023.07.007_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.120.053216","article-title":"Spending on cardiovascular disease and cardiovascular risk factors in the United States: 1996 to 2016","volume":"144","author":"Birger","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.07.007_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College\u00a0of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2023.07.007_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2023.07.007_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2023.07.007_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2023.07.007_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2023.07.007_bib12","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2023.07.007_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological\u00a0practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2023.07.007_bib14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIR.0000000000000042","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"129","author":"Anderson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.07.007_bib15","first-page":"1","article-title":"United States Life Tables. 2020","volume":"71","author":"Arias","year":"2022","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.hroo.2023.07.007_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/eut395","article-title":"The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification","volume":"16","author":"Wynn","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2023.07.007_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011237","article-title":"Economic and health value of delaying atrial fibrillation progression using radiofrequency catheter ablation","volume":"16","author":"Berman","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2023.07.007_bib18","first-page":"929","article-title":"The influence of progression of atrial fibrillation on quality of life: a report from the","volume":"20","author":"Dudink","year":"2018","journal-title":"Euro Heart Survey. Europace"},{"key":"10.1016\/j.hroo.2023.07.007_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.122.058575","article-title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation: the CABANA randomized clinical trial","volume":"146","author":"Chew","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023237","article-title":"Identification of incident atrial fibrillation from electronic medical records","volume":"11","author":"Chamberlain","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2023.07.007_bib21","author":"Cubanski"},{"key":"10.1016\/j.hroo.2023.07.007_bib25","series-title":"Standard Analytical Files (Medicare Claims) - LDS","year":"2016"},{"key":"10.1016\/j.hroo.2023.07.007_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated\u00a0with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2023.07.007_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006043","article-title":"The impact of cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation on healthcare utilization and costs: an economic analysis from the FIRE AND ICE trial","volume":"6","author":"Chun","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2023.07.007_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/cer-2020-0224","article-title":"Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke","volume":"10","author":"Sawyer","year":"2021","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.hroo.2023.07.007_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/STROKEAHA.116.014735","article-title":"Cost-effectiveness of solitaire stent retriever thrombectomy for acute ischemic stroke: results from the SWIFT-PRIME trial (solitaire with the intention for thrombectomy as primary endovascular treatment for acute ischemic stroke)","volume":"48","author":"Shireman","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.hroo.2023.07.007_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4037\/ajcc2002.11.5.474","article-title":"Outpatient costs of medications for patients with chronic heart failure","volume":"11","author":"Hussey","year":"2002","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.hroo.2023.07.007_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardfail.2010.01.007","article-title":"Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus","volume":"16","author":"Bogner","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.hroo.2023.07.007_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226730","article-title":"Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation","volume":"14","author":"Witassek","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.hroo.2023.07.007_bib33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1524-4733.2008.00425.x","article-title":"Utility estimates for decision\u2013analytic modeling in chronic heart failure\u2014health states based on New York Heart Association\u00a0classes and number of rehospitalizations","volume":"12","author":"G\u00f6hler","year":"2009","journal-title":"Value Health"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501823001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501823001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:26:35Z","timestamp":1762993595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501823001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666501823001666"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2023.07.007","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}